Inventor
ALMEIDA LAUREN J
US14 patents
⚠️ This page may combine multiple inventors who share the name “ALMEIDA LAUREN J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARROWHEAD PHARMACEUTICALS INC
12 patentsUS10130651B2Nov 20, 2018
RNAi Therapy for Hepatitis B Virus Infection
ARROWHEAD PHARMACEUTICALS INC22 citations94
US10780108B2Sep 22, 2020
RNAi agents for Hepatitis B virus infection
ARROWHEAD PHARMACEUTICALS INC5 citations82
US10662427B2May 26, 2020
Compositions and methods for inhibiting gene expression of LPA
ARROWHEAD PHARMACEUTICALS INC6 citations82
US9932586B2Apr 3, 2018
Compositions and methods for inhibiting gene expression of LPA
ARROWHEAD PHARMACEUTICALS INC9 citations82
US10806750B2Oct 20, 2020
RNAi therapy for hepatitis B virus infection
ARROWHEAD PHARMACEUTICALS INC3 citations73
US10308941B2Jun 4, 2019
Compositions and methods for inhibiting gene expression of factor XII
ARROWHEAD PHARMACEUTICALS INC4 citations73
US11590156B2Feb 28, 2023
RNAi agents for hepatitis B virus infection
ARROWHEAD PHARMACEUTICALS INC2 citations72
US11517584B2Dec 6, 2022
RNAi agents for Hepatitis B virus infection
ARROWHEAD PHARMACEUTICALS INC2 citations72
US10927373B2Feb 23, 2021
Compositions and methods for inhibiting gene expression of Hif2alpha
ARROWHEAD PHARMACEUTICALS INC2 citations71
US11534453B2Dec 27, 2022
RNAi therapy for hepatitis B virus infection
ARROWHEAD PHARMACEUTICALS INC0 citations62
US11840688B2Dec 12, 2023
Compositions and methods for inhibiting gene expression of Hif2alpha
ARROWHEAD PHARMACEUTICALS INC0 citations61
US10858658B2Dec 8, 2020
Compositions and methods for inhibiting gene expression of factor XII
ARROWHEAD PHARMACEUTICALS INC0 citations52